NEWSNews
From March 12 to 14, 2026, the 11th BIOCHINA Exhibition (BIO CHINA 2026) was grandly held at the Suzhou International Expo Center. As the official authorized distributor of Pfanstiehl in China, Beijing XMJ Technology Co., Ltd. joined Pfanstiehl at Booth 078, Hall E3 (Raw Materials & Reagents), showcasing a comprehensive portfolio of injectable-grade pharmaceutical excipients and high-quality upstream process raw materials. The booth attracted extensive engagement from industry peers, generating in-depth discussions and business exchanges throughout the event.
At the exhibition, Pfanstiehl — a century-old brand with a legacy of excellence — made a powerful appearance with its full range of injectable-grade pharmaceutical excipients. Featuring ultra-high purity, ultra-low endotoxin levels, and ultra-low metal ion content, Pfanstiehl's products delivered a new benchmark for high-compliance raw material solutions to China's biopharmaceutical industry, drawing significant attention from formulation scientists, R&D engineers, and procurement professionals alike. The booth was a hub of vibrant activity, with attendees engaging in substantive discussions on trending topics such as the evolving landscape of subcutaneous drug delivery and the technical challenges of viscosity reduction in high-concentration antibody formulations.

As the official authorized distributor of Pfanstiehl in China, XMJ goes beyond product supply — leveraging deep industry expertise and a dedicated technical team to provide customers with end-to-end support across the full drug development lifecycle. From rapid screening and formulation optimization in early-stage R&D to large-scale, reliable supply for commercial manufacturing, XMJ delivers proven solutions at every stage. Pfanstiehl's rigorous quality control system effectively helps clients accelerate formulation development and streamline regulatory submission processes. During the exhibition, the XMJ team engaged in extensive discussions with pharmaceutical companies and research institutions, gaining valuable insights into customer needs while further strengthening partnerships across the industry.

Featured Products at This Exhibition
Injectable-Grade Sugar Alcohols:Trehalose, Sucrose, Mannitol
Injectable-Grade Amino Acids:Histidine, Histidine HCl, Arginine, Arginine HCl, L-Methionine, Glycine, Arginine Glutamate
Injectable-Grade Buffer Systems:Tris Base, Tris HCl, Succinic Acid & Sodium Succinate Buffer System
GMP-Grade Upstream Process Materials:Methotrexate (Powder), Methotrexate (Liquid), Galactose, Mannose, Glutamine, Glucose


Pfanstiehl's injectable-grade excipients and GMP-grade upstream process materials offer a comprehensive product portfolio that fully addresses the demands of biopharmaceutical R&D and large-scale production. Notably, in response to critical industry challenges — including the development of complex biological formulations and viscosity reduction in high-concentration drug products —four new products made their official debut at this exhibition: injectable-grade Glycine (G-140) and Arginine Glutamate (A-172), alongside GMP-grade upstream process materials Methotrexate Powder (M-166) and Methotrexate Solution (M-166-S), further expanding Pfanstiehl's high-quality solutions for next-generation biologics development and manufacturing.
Beijing XMJ Technology Co., Ltd., as the official authorized distributor of Pfanstiehl in China, provides comprehensive one-stop services including stable inventory supply, professional technical support, and regulatory submission assistance. Follow the XMJ WeChat Official Account and navigate to"Customer Service"via the bottom menu to request a complimentary 100g Pfanstiehl test sample. For inquiries, please contact our hotline:400-050-4006, or visit our official website at m.lxhmstone.com.
京公網(wǎng)安備 11010802028692號(hào)